Standard Operating Procedure for Identifying Policy Changes That Affect Product Registrations
| Department | Regulatory Affairs |
| SOP No. | RA/2026/633 |
| Supersedes | NA |
| Page No. | 1 of X |
| Issue Date | 09/04/2026 |
| Effective Date | 09/04/2026 |
| Review Date | 09/04/2028 |
Purpose
This Standard Operating Procedure (SOP) defines the systematic approach for identifying and monitoring regulatory policy changes that can impact existing product registrations. The objective is to ensure timely awareness and compliance with evolving regulatory requirements to maintain product approvals and market access. This SOP supports the control objective of maintaining regulatory intelligence for proactive risk mitigation and ensuring continued product compliance.
Scope
This SOP applies to all regulatory affairs personnel responsible for monitoring regulatory policies, guidelines, and legislation at local, regional, and global levels that could affect pharmaceutical product registrations. It covers policy changes related to any dosage form, product category, or therapeutic area registered by the organization. The SOP includes processes for information sourcing, assessment, documentation, and communication of relevant policy changes. It excludes unrelated internal organizational policies and non-regulatory news.
Responsibilities
- Regulatory Intelligence Team: Responsible for sourcing, tracking, and initial screening of policy changes.
- Regulatory Affairs Analysts: Perform detailed impact assessments on affected products.
- Regulatory Affairs Manager: Reviews assessments and approves communication plans.
- Quality Assurance: Oversees compliance verification and audit readiness related to policy change impacts.
- Documentation Specialist: Maintains records of identified changes and corresponding actions.
Accountability
The Regulatory Affairs Head is accountable for the implementation, compliance, timely review, escalation of significant policy changes, and periodic evaluation of this SOP’s effectiveness. They ensure appropriate resources are allocated, and necessary communications are made to stakeholders to maintain regulatory compliance and facilitate continuous product registration conformity.
Procedure
1. Preparation and Prerequisites: Ensure access to authoritative regulatory databases, official government websites, industry newsletters, and subscription services. Maintain a current list of regulatory agencies relevant to product registrations.
2. Identification and Monitoring: Continuously monitor multiple regulatory sources for policy updates, draft guidelines, circulars, notifications, and amendments that may affect product registrations.
3. Initial Screening: The Regulatory Intelligence Team reviews identified policy changes daily or weekly depending on urgency, filtering for those relevant to product registrations held by the company.
4. Impact Assessment: Regulatory Affairs Analysts conduct a detailed analysis on how the policy change affects existing registrations, documentation, submission requirements, labeling, or compliance status. Assessment includes regulatory timelines and possible risks.
5. Documentation and Reporting: Enter the details of policy changes and assessment outcomes into the Regulatory Intelligence Log (Annexure-1). Prepare an impact summary report for senior management review.
6. Communication: Regulatory Affairs Manager reviews assessments and authorizes the dissemination of information to relevant internal stakeholders such as Regulatory Operations, Quality, Manufacturing, and Compliance departments.
7. Action Plan Development: Collaborate with stakeholders to develop and implement mitigation or adaptation actions such as submission updates, product relabeling, or additional documentation preparation.
8. Approval and Follow-up: Ensure management approval of action plans. Track actions to completion and update the Regulatory Intelligence Log accordingly.
9. Compliance Verification: Quality Assurance conducts periodic audits to verify adherence to regulatory changes identified and implemented through this SOP.
10. Record Retention and Closure: All records related to policy identification, impact assessments, communications, and corrective actions shall be retained as per company document retention policy and regulatory requirements. Close each policy change record after verification of full implementation.
11. Deviation Handling: Any deviations from this SOP or regulatory requirements must be documented and managed per the deviation management process, with root cause analysis and corrective actions.
This procedure ensures a standardized, timely, and compliant approach to regulatory policy change monitoring, supporting uninterrupted product market access and regulatory adherence.
Abbreviations
- SOP – Standard Operating Procedure
- RA – Regulatory Affairs
- QA – Quality Assurance
- GMP – Good Manufacturing Practice
- API – Active Pharmaceutical Ingredient
Documents
The following documents are required to support this SOP:
- Regulatory Intelligence Log (Annexure-1)
- Policy Change Impact Assessment Report Template (Annexure-2)
- Regulatory Communication Memo Template (Annexure-3)
References
- ICH Q10 Pharmaceutical Quality System Guidelines
- FDA Guidance for Industry on Regulatory Procedures
- EMA Regulatory Guidance Documents
- Company Quality Management System Documentation
- ISO 9001:2015 – Quality Management Systems Requirements
- Relevant National Regulatory Authority Policies and Guidelines
Version
1.0
Approval
| Prepared By | |
| Checked By | |
| Approved By |
Annexures
Annexure-1: Regulatory Intelligence Log
Purpose: To document and track all identified regulatory policy changes potentially affecting product registrations, including initial screening details and follow-up status.
| Date Identified | Policy Source | Policy Title/Reference | Initial Screening Result | Action Required | Status |
|---|---|---|---|---|---|
| 05/04/2026 | FDA Website | New Labeling Requirements for OTC Products | Relevant | Impact Assessment Initiated | In Progress |
| 07/04/2026 | EMA Newsletter | Revision of GMP Inspection Frequency | Not Applicable | No Action | Closed |
Annexure-2: Policy Change Impact Assessment Report Template
Purpose: To document detailed assessment of the impact a regulatory policy change has on registered products and necessary regulatory actions.
| Policy Reference: | New Labeling Requirements for OTC Products |
| Date of Assessment: | 06/04/2026 |
| Products Affected: | Product A, Product B |
| Summary of Impacts: | Labeling changes required to include new warning statements. Submission of variation applications anticipated. |
| Recommended Actions: | Initiate label revision process, prepare regulatory submissions, update master documents. |
| Assessment Conducted By: | Regulatory Affairs Analyst |
| Review and Approval: | Regulatory Affairs Manager |
Annexure-3: Regulatory Communication Memo Template
Purpose: To communicate the details of identified regulatory policy changes and required actions to relevant internal departments ensuring awareness and coordinated response.
| Date: | 07/04/2026 |
| To: | Manufacturing, Quality, Compliance, Documentation |
| From: | Regulatory Affairs Department |
| Subject: | Notification of New Labeling Regulations for OTC Products |
| Summary: | New regulatory labeling requirements effective from 01/06/2026 requiring label revision for OTC products. Actions include label updates, documentation revision, and submission to authorities. |
| Required Actions: | Initiate label modification, update master files, prepare regulatory submissions prior to effective date. |
| Point of Contact: | Regulatory Affairs Manager |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
| 09/04/2026 | 1.0 | Initial issue | New SOP creation |